MIDODRINE AND PLACEBO IN MIDODRINE RESPONDER PATIENTS--ORTHOSTATIC HYPOTENSION

米多君和安慰剂在米多君应答患者中的应用——体位性低血压

• 批准号: 3785277
• 负责人: HORACIO KAUFMANN
• 金额: --
• 依托单位: MOUNT SINAI SCHOOL OF MEDICINE OF CUNY
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3785277
• 关键词: antihypertensive agents; cardiovascular disorder chemotherapy; clinical trials; human subject; human therapy evaluation; postural hypotension; syncope; vasoconstrictors

Objective is to evaluate the efficacy of midodrine as compared to placebo to inhibit symptoms of syncope due to orthostatic hypotension (lightheadedness/dizziness and dimming or blurring of vision) and to improve upright systolic blood pressure.

目的是评价米多君与安慰剂相比的疗效 抑制因体位性低血压引起的晕厥症状 （头晕/头晕和视力变暗或模糊）， 改善直立收缩压。